Delving into the Latest Updates on The 458 Hospital Of Chinese People'S Liberation Army with Synapse

概览

关联

1

项与 The 458 Hospital Of Chinese People'S Liberation Army 相关的药物

Hepatitis B DNA vaccine(Guangzhou Baiyunshan Bai Di Bio-technology Co., Ltd.)

治疗性双质粒HBV DNA疫苗(Guangzhou Baiyunshan Bai Di Bio-technology)

靶点-

作用机制

免疫刺激剂

在研机构-

原研机构

广州白云山拜迪生物医药有限公司

在研适应症-

非在研适应症

慢性乙型肝炎

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

2

项与 The 458 Hospital Of Chinese People'S Liberation Army 相关的临床试验

NCT02094638 / CompletedN/AIIT

Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study

Tanreqing Injection is widely used in respiratory disease with Chinese medicine syndrome of retention of phlegm and heat in Fei. This study record clinical use of Tanreqing Injection in the real world, observe the adverse drug reactions/ adverse drug events during treatment, and figure out why Tanreqing induced severe allergic reaction happens.

开始日期2014-01-01

申办/合作机构

北京大学第三医院

[+36]

NCT01600196 / Terminated临床4期IIT

Surgical Resection Versus Best Supportive Care for Resectable Hepatocellular Carcinoma Invading the First Branch of Portal Vein

The purpose of this study is to evaluate the long-term efficacy and safety of surgical resection compared with best supportive care in patients with resectable hepatocellular carcinoma (HCC) with portal venous thrombus (PVTT) in the first branch of portal vein.

开始日期2006-01-01

申办/合作机构

中山大学

[+1]

100 项与 The 458 Hospital Of Chinese People'S Liberation Army 相关的临床结果

登录后查看更多信息

0 项与 The 458 Hospital Of Chinese People'S Liberation Army 相关的专利（医药）

登录后查看更多信息

2

项与 The 458 Hospital Of Chinese People'S Liberation Army 相关的文献（医药）

2015-10-01·Zhonghua wai ke za zhi [Chinese journal of surgery]

[Combined application of neuroendoscope and laparoscope in ventriculo-peritoneal shunt for treatment of communicating hydrocephalus].

Article

作者: Yu, Xinguang ; Song, Zhijun ; Zhang, Jianfeng ; Zhou, Dingbiao ; Chen, Xiaolei ; Tang, Yunlin ; Sun, Jin

OBJECTIVETo summarize the clinical efficacy of ventriculo-peritoneal shunt (VPS) assisted by neuroendoscopy and laparoscopy for treatment of communicating hydrocephalus.METHODSFrom January 2010 to January 2014, 209 cases (male 93, female 116) who suffered communicating hydrocephalus performed VPS with neuroendoscopy and laparoscopy in Department of Neurosurgery of People's Liberation Army General Hospital. The age of the patients were from 7 months to 79 years (mean 38.1 years), average duration were 20 days to 4 years (mean (2.4 ± 0.7) months). Neuroendoscopy and laparoscopy were used to help respectively to place shunt catheter to better position, both in the ventricle and peritoneal cavity. The effect of subsequent shunt system survival was analyzed with Kaplan-Meier survival analysis.RESULTSThere were 209 patients received 255 times of VPS. All operations were successfully completed. No craniotomy or open operation were needed for technical-related complications. Forty-six revisions were performed in all patients. After the operation, 203 patients with hydrocephalus improved at different level after surgery. Thirteen cases occurred intracranial hypotension syndrome and improved after the pressure adjusted. All patients were followed up for 1 month to 4 years, with a median follow-up time of 2.1 years, while the shunt system efficiencies were 91.0%, 86.7%, 83.9% and 82.0% respectively from the end of the 1st year to the end of the 4th year.CONCLUSIONSFor VPS, neuroendoscopy and laparoscopy can respectively help to place shunt catheter to better position, both in the ventricle and peritoneal cavity. Hence, the combination of these two modalities can reduce the failure rate of shunt catheter insertion and has significant impact on shunt system survival.

Chinese journal of surgery

[Combined application of neuroendoscope and laparoscope in ventriculo-peritoneal shunt for treatment of communicating hydrocephalus].

作者: Xiaolei Chen ; Jin Sun ; Zhijun Song ; Dingbiao Zhou ; Xinguang Yu ; Jianfeng Zhang ; Yunlin Tang

Objective To summarize the clinical efficacy of ventriculo-peritoneal shunt(VPS) assisted by neuroendoscopy and laparoscopy for treatment of communicating hydrocephalus. Methods From January 2010 to January 2014, 209 cases(male 93, female 116) who suffered communicating hydrocephalus performed VPS with neuroendoscopy and laparoscopy in Department of Neurosurgery of People's Liberation Army General Hospital. The age of the patients were from 7 months to 79 years (mean 38.1 years), average duration were 20 days to 4 years (mean (2.4±0.7) months). Neuroendoscopy and laparoscopy were used to help respectively to place shunt catheter to better position, both in the ventricle and peritoneal cavity. The effect of subsequent shunt system survival was analyzed with Kaplan-Meier survival analysis. Results There were 209 patients received 255 times of VPS. All operations were successfully completed. No craniotomy or open operation were needed for technical-related complications. Forty-six revisions were performed in all patients. After the operation, 203 patients with hydrocephalus improved at different level after surgery. Thirteen cases occurred intracranial hypotension syndrome and improved after the pressure adjusted. All patients were followed up for 1 month to 4 years, with a median follow-up time of 2.1 years, while the shunt system efficiencies were 91.0%, 86.7%, 83.9% and 82.0% respectively from the end of the 1st year to the end of the 4th year. Conclusions For VPS, neuroendoscopy and laparoscopy can respectively help to place shunt catheter to better position, both in the ventricle and peritoneal cavity. Hence, the combination of these two modalities can reduce the failure rate of shunt catheter insertion and has significant impact on shunt system survival. Key words: Hydrocephalus; Ventriculoperitoneal shunt; Neuroendoscopy; Laparoscopy

100 项与 The 458 Hospital Of Chinese People'S Liberation Army 相关的药物交易

登录后查看更多信息

100 项与 The 458 Hospital Of Chinese People'S Liberation Army 相关的转化医学

登录后查看更多信息